EV/EBITDA
-1.63
+0.05+2.98%
3 min ago
Summary
- As of March 3, 2025, ADAP EV/EBITDA is -1.63, with a rise of +0.05 (+2.98%) during the most recent trading day.
- Over the past year, ADAP EV/EBITDA has increased by +0.23 (+12.37%).
- ADAP EV/EBITDA is now -443.33% below its all-time high of -0.30.
Performance
ADAP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ADAP EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.0% | -2.6% | -1.8% |
| 1 m1 month | +18.1% | -18.0% | -13.1% |
| 3 m3 months | +33.5% | -33.3% | -25.5% |
| 6 m6 months | +29.4% | -36.7% | -56.5% |
| ytdytd | +3.5% | -3.2% | -2.3% |
| 1 y1 year | +12.4% | -60.7% | -66.2% |
| 5 y5 years | +50.1% | -78.3% | -84.8% |
ADAP EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -2.01 | +18.9% | |
| 3 m | 3-month | -1.63 | at high | -2.57 | +36.6% |
| 6 m | 6-month | -1.16 | -40.5% | -2.59 | +37.1% |
| 1 y | 1-year | -0.53 | -207.6% | -3.11 | +47.6% |
| 3 y | 3-year | -0.30 | -443.3% | -3.11 | +47.6% |
| 5 y | 5-year | -0.30 | -443.3% | -13.19 | +87.6% |
| alltime | all time | -0.30 | -443.3% | -257.80 | +99.4% |
Adaptimmune Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.63(-3.6%) |
| 2024 | -1.69(+259.6%) |
| 2023 | -0.47(-52.0%) |
| 2022 | -0.98(-66.9%) |
| 2021 | -2.96(-53.5%) |
| Date | Value |
|---|---|
| 2020 | -6.37(+727.3%) |
| 2019 | -0.77(-89.2%) |
| 2018 | -7.12(-1.1%) |
| 2017 | -7.20(+297.8%) |
| 2016 | -1.81(-96.8%) |
| 2015 | -56.20 |
FAQ
- What is Adaptimmune Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Adaptimmune Therapeutics?
- What is ADAP EV/EBITDA year-to-date change?
- What is Adaptimmune Therapeutics EV/EBITDA year-on-year change?
What is Adaptimmune Therapeutics EV/EBITDA?
The current EV/EBITDA of ADAP is -1.63
What is the all time high EV/EBITDA for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high EV/EBITDA is -0.30
What is ADAP EV/EBITDA year-to-date change?
Adaptimmune Therapeutics EV/EBITDA has changed by +0.06 (+3.55%) since the beginning of the year
What is Adaptimmune Therapeutics EV/EBITDA year-on-year change?
Over the past year, ADAP EV/EBITDA has changed by +0.23 (+12.37%)